Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 123

1.

Commercial Intravenous Immunoglobulin (IVIg) Preparations Contain Functional Neutralizing Antibodies Against the Staphylococcus aureus Leukocidin LukAB (LukGH).

Wood JB, Jones LS, Soper NR, Nagarsheth M, Creech CB, Thomsen IP.

Antimicrob Agents Chemother. 2017 Sep 5. pii: AAC.00968-17. doi: 10.1128/AAC.00968-17. [Epub ahead of print]

PMID:
28874371
2.

Comparison of Clinical Trial and Systematic Review Outcomes for the 4 Most Prevalent Eye Diseases.

Saldanha IJ, Lindsley K, Do DV, Chuck RS, Meyerle C, Jones LS, Coleman AL, Jampel HD, Dickersin K, Virgili G.

JAMA Ophthalmol. 2017 Sep 1;135(9):933-940. doi: 10.1001/jamaophthalmol.2017.2583.

PMID:
28772305
3.

Monoclonal Antibodies Against the Staphylococcus aureus Bicomponent Leukotoxin AB Isolated Following Invasive Human Infection Reveal Diverse Binding and Modes of Action.

Thomsen IP, Sapparapu G, James DBA, Cassat JE, Nagarsheth M, Kose N, Putnam N, Boguslawski KM, Jones LS, Wood JB, Creech CB, Torres VJ, Crowe JE Jr.

J Infect Dis. 2017 Apr 1;215(7):1124-1131. doi: 10.1093/infdis/jix071.

PMID:
28186295
4.

Pleural effusion: An uncommon manifestation of nitrofurantoin-induced pulmonary injury.

Davis JW, Jones LS.

Respir Med Case Rep. 2016 Jul 20;19:65-7. doi: 10.1016/j.rmcr.2016.07.009. eCollection 2016.

5.

Right iliac fossa pain from a grossly enlarged and torted appendix in a patient with known colitis.

Seager A, Gill M, Jones LS.

Ann R Coll Surg Engl. 2016 Sep;98(7):e136-7. doi: 10.1308/rcsann.2016.0179. Epub 2016 Jun 8.

6.

Post-vaccination MDEM associated with MOG antibody in a subclinical Chlamydia infected boy.

Azumagawa K, Nomura S, Shigeri Y, Jones LS, Sato DK, Nakashima I, Kashiwagi M, Tanabe T, Shimakawa S, Nakajima H, Tamai H.

Brain Dev. 2016 Aug;38(7):690-3. doi: 10.1016/j.braindev.2016.02.004. Epub 2016 Feb 24.

PMID:
26922251
7.

Host response to Staphylococcus aureus cytotoxins in children with cystic fibrosis.

Chadha AD, Thomsen IP, Jimenez-Truque N, Soper NR, Jones LS, Sokolow AG, Torres VJ, Creech CB.

J Cyst Fibros. 2016 Sep;15(5):597-604. doi: 10.1016/j.jcf.2015.12.023. Epub 2016 Jan 25.

8.

The Effect of Food and Formulation on the Pharmacokinetics, Safety, and Tolerability of GSK1322322 in Healthy Volunteers.

Naderer O, Jones LS, Zhu J, Coffin MD, Kurtinecz M, Dumont E.

Clin Pharmacol Drug Dev. 2015 Jan;4(1):49-55. Epub 2014 Oct 27.

9.

Pharmacokinetics of hepatitis C virus NS5A inhibitor JNJ-56914845 (GSK2336805) in subjects with hepatic impairment.

Adkison KK, Gan J, Elko-Simms L, Gardner S, Dumont E, Jones LS, Saunders J, Marbury T, Smith W, Berg J, Galloway C, Stump PJ.

J Clin Pharmacol. 2015 Sep;55(9):1042-50. doi: 10.1002/jcph.512. Epub 2015 May 25.

PMID:
25857714
10.

Comparison of Cancer-specific and General Health Literacy Assessments in an Educated Population: Correlations and Modifying Factors.

Jenkins WD, Zahnd WE, Spenner A, Wiley C, Roles R, Potini Y, Jones LS.

J Cancer Educ. 2016 Jun;31(2):268-71. doi: 10.1007/s13187-015-0816-1.

PMID:
25820603
11.

Characterization of plasmids in extensively drug-resistant acinetobacter strains isolated in India and Pakistan.

Jones LS, Carvalho MJ, Toleman MA, White PL, Connor TR, Mushtaq A, Weeks JL, Kumarasamy KK, Raven KE, Török ME, Peacock SJ, Howe RA, Walsh TR.

Antimicrob Agents Chemother. 2015 Feb;59(2):923-9. doi: 10.1128/AAC.03242-14. Epub 2014 Nov 24.

12.

Effects of omeprazole and ritonavir on absorption and elimination of the hepatitis C virus NS5A inhibitor GSK2336805 in healthy adults.

Adkison KK, Jones LS, Lou Y, Gan J, Wilfret DA.

Clin Pharmacol Drug Dev. 2014 Sep;3(5):338-45. doi: 10.1002/cpdd.104. Epub 2014 Feb 18.

PMID:
27129005
13.

Safety, tolerability, and efficacy of GSK1322322 in the treatment of acute bacterial skin and skin structure infections.

Corey R, Naderer OJ, O'Riordan WD, Dumont E, Jones LS, Kurtinecz M, Zhu JZ.

Antimicrob Agents Chemother. 2014 Nov;58(11):6518-27. doi: 10.1128/AAC.03360-14. Epub 2014 Aug 18.

14.

Plasmid carriage of bla NDM-1 in clinical Acinetobacter baumannii isolates from India.

Jones LS, Toleman MA, Weeks JL, Howe RA, Walsh TR, Kumarasamy KK.

Antimicrob Agents Chemother. 2014 Jul;58(7):4211-3. doi: 10.1128/AAC.02500-14. Epub 2014 Apr 21.

15.

The multiplicity of post-translational modifications in pro-opiomelanocortin-derived peptides.

Yasuda A, Jones LS, Shigeri Y.

Front Endocrinol (Lausanne). 2013 Dec 2;4:186. doi: 10.3389/fendo.2013.00186. Review.

16.

Penetration of GSK1322322 into epithelial lining fluid and alveolar macrophages as determined by bronchoalveolar lavage.

Naderer OJ, Rodvold KA, Jones LS, Zhu JZ, Bowen CL, Chen L, Dumont E.

Antimicrob Agents Chemother. 2014;58(1):419-23. doi: 10.1128/AAC.01836-13. Epub 2013 Nov 4.

17.

Safety, tolerability, and pharmacokinetics of oral and intravenous administration of GSK1322322, a peptide deformylase inhibitor.

Naderer OJ, Jones LS, Zhu J, Kurtinecz M, Dumont E.

J Clin Pharmacol. 2013 Nov;53(11):1168-76. doi: 10.1002/jcph.150. Epub 2013 Aug 13.

PMID:
23907665
18.

Application of multiplexed kinase inhibitor beads to study kinome adaptations in drug-resistant leukemia.

Cooper MJ, Cox NJ, Zimmerman EI, Dewar BJ, Duncan JS, Whittle MC, Nguyen TA, Jones LS, Ghose Roy S, Smalley DM, Kuan PF, Richards KL, Christopherson RI, Jin J, Frye SV, Johnson GL, Baldwin AS, Graves LM.

PLoS One. 2013 Jun 24;8(6):e66755. doi: 10.1371/journal.pone.0066755. Print 2013.

19.

Safety, tolerability and pharmacokinetics of orally inhaled zanamivir: a randomized study comparing Rotacap/Rotahaler and Rotadisk/Diskhaler in healthy adults.

Weller S, Jones LS, Lou Y, Piscitelli S, Peppercorn A, Ng-Cashin J.

Antivir Ther. 2013;18(6):827-30. doi: 10.3851/IMP2631. Epub 2013 May 21.

PMID:
23696221
20.

Pharmacokinetics of zanamivir following intravenous administration to subjects with and without renal impairment.

Weller S, Jones LS, Lou Y, Peppercorn A, Ng-Cashin J.

Antimicrob Agents Chemother. 2013 Jul;57(7):2967-71. doi: 10.1128/AAC.02330-12. Epub 2013 Apr 15.

Supplemental Content

Loading ...
Support Center